Biotransformation enzymes in human intestine: critical low levels in the colon?

W H Peters, L Kock, F M Nagengast, P G Kremers

Division of Gastrointestinal and Liver Diseases, St Radboud Hospital, Nijmegen, The Netherlands.

Biotransformation or drug-metabolising enzymes have an important function in the detoxication of ingested toxic, carcinogenic, or tumour promoting compounds. Enzyme activity and isoenzyme composition of three biotransformation systems: glutathione S-transferase, uridine diphosphate-glucuronosyltransferase, and cytochrome P-450 were studied in normal small and large intestinal mucosa from three kidney donors. The activity of most drug-metabolising enzymes decreases slightly from proximal to distal small intestine, whereas in the mucosa of the large intestine a sharp fall in activity was observed. The isoenzyme composition for each of the three biotransformation systems changed from the small to the large intestine. Class Alpha glutathione S-transferases were not expressed in the colon, in contrast to the small intestine where both Alpha and Pi class isoenzymes are present. In addition, with monoclonal antibodies fewer protein bands for UDP-glucuronosyltransferases and cytochrome P-450 were detected in the colon. In the small intestine both isoforms P-450(4) and P-450(5) were present, whereas in the colon only reduced amounts of cytochrome P-450(4) could be visualised. For UDP-glucuronosyltransferase, 53 and 54 kDa proteins could be detected in the small intestine, but in the colon there was only weak staining of the 54 kDa band. In the normal human colon enzymes are less active and there are fewer isoenzymes present in the mucosa than in the small intestine. This implies a lower level of the detoxifying potential in the colon, which might be important in regard to the high rates of carcinogenesis in the colon.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Tijhuis, M. J., Visker, M. H.P.W., Aarts, J. M.M.J.G., Peters, W. H.M., Roelofs, H. M.J., Camp, L. O. d., Rietjens, I. M.C.M., Boerboom, A.-M. J.F., Nagengast, F. M., Kok, F. J., Kampman, E. (2007). Glutathione S-transferase phenotypes in relation to genetic variation and fruit and vegetable consumption in an endoscopy-based population. Carcinogenesis 28: 848-857 [Abstract] [Full Text]  
• Theiss, A. L., Idell, R. D., Srinivasan, S., Klapproth, J.-M., Jones, D. P., Merlin, D., Sitaraman, S. V. (2007). Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J. 21: 197-206 [Abstract] [Full Text]  
• Wark, P. A., Grubben, M. J.A.L., Peters, W. H.M., Nagengast, F. M., Kampman, E., Kok, F. J., van 't Veer, P. (2004). Habitual consumption of fruits and vegetables: associations with human rectal glutathione S-transferase. Carcinogenesis 25: 2135-2142 [Abstract] [Full Text]  
• Kaminsky, L. S., Zhang, Q.-Y. (2003). THE SMALL INTESTINE AS A XENOBIOTIC-METABOLIZING ORGAN. Drug Metab. Dispos. 31: 1520-1525 [Full Text]  
• van der Logt, E.M.J., Roelofs, H.M.J., Nagengast, F.M., Peters, W.H.M. (2003). Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 24: 1651-1656 [Abstract] [Full Text]  
• Hoensch, H, Morgenstern, I, Petereit, G, Siepmann, M, Peters, W H M, Roelofs, H M J, Kirch, W (2002). Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system. Gut 50: 235-240 [Abstract] [Full Text]  
• Tukey, R. H., Strassburg, C. P. (2001). Genetic Multiplicity of the Human UDP-Glucuronosyltransferases and Regulation in the Gastrointestinal Tract. Mol. Pharmacol. 59: 405-414 [Abstract] [Full Text]  
• Cheng, Z., Radominska-Pandya, A., Tephly, T. R. (1999). Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10. Drug Metab. Dispos. 27: 1165-1170 [Abstract] [Full Text]  
• Lin, J. H., Chiba, M., Baillie, T. A. (1999). Is the Role of the Small Intestine in First-Pass Metabolism Overemphasized?. Pharmacol. Rev. 51: 135-158 [Abstract] [Full Text]  
• van Lieshout, E. M. M., Roelofs, H. M. J., Dekker, S., Mulder, C. J. J., Wobbes, T., Jansen, J. B. M. J., Peters, W. H. M. (1999). Polymorphic Expression of the Glutathione Polymorphic Expression of the Glutathione S-Transferase P1 Gene and Its Susceptibility to Barrett's Esophagus and Esophageal Carcinoma. Cancer Res. 59: 586-589 [Abstract] [Full Text]  
• Gibbs, J. P., Yang, J.-S., Slattery, J. T. (1998). Comparison of Human Liver and Small Intestinal Glutathione S-Transferase-Catalyzed Busulfan Conjugation in Vitro. Drug Metab. Dispos. 26: 52-55 [Abstract] [Full Text]  
• ROEDIGER, W. E W, BABIDGE, W. (1997). Human colonocyte detoxification. Gut 41: 731-734 [Full Text]